TipRanks
TipRanksTop Financial ExpertsInsidersSanofi

Sanofi Insider Profile

18 Followers
Sanofi, Ten Percent Owner at Latigo Biotherapeutics, Inc., holds 672.79K shares in Latigo Biotherapeutics, Inc. (Ticker: LTGO), holds 1.08M shares in Attovia Therapeutics, Inc. (Ticker: ATTO), holds 75.67M shares in Translate Bio (Ticker: ~TBIO).
See the Hottest Stocks Based on Insider Trading >
tipranks
Sanofi

Sanofi
Latigo Biotherapeutics, Inc. (LTGO)
Ten Percent Owner

Ranked #3,355 out of 109,349 Corporate Insiders

Profitable Transactions

60%
31 out of 52 Profitable Transactions

Average Return

+15.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$2B
84.52%
12.96%
0.82%
0.80%
0.89% Others
A breakdown of Sanofi's holdings
See the Top Stocks by Insiders

Insider Roles

Alnylam Pharma
(ALNY)
Ten Percent Owner
Regeneron
(REGN)
Ten Percent Owner
Attovia Therapeutics, Inc.
(ATTO)
Ten Percent Owner
Crescent Biopharma
(CBIO)
Ten Percent Owner
+3 other positions
Roles that Sanofi holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
MyoKardia
(MYOK)
Rating:Informative Buy
Date:Oct 05, 2016 - Oct 05, 2017
Return:+145.60%
The most profitable trade made by Sanofi
See the Latest Stocks Traded by Insiders

Sanofi's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
LTGO
Latigo Biotherapeutics, Inc.
Aug 12, 2026
Ten Percent Owner
Uninformative Buy
―
$9.39M
REGN
Regeneron
Jun 11, 2020
Ten Percent Owner
Informative Sell
71.84M
$259.59M
MYOK
MyoKardia
Feb 15, 2019
―
Informative Sell
157.00M
$0.00
FULC
Fulcrum Therapeutics
Jul 23, 2019
Ten Percent Owner
Uninformative Buy
―
$2.07M
INZY
Inozyme Pharma
Jul 29, 2020
―
Informative Buy
1.30M
$2.08M
ICVX
Icosavax
Aug 02, 2021
―
Informative Buy
1.00M
$48.31M
~TBIO
Translate Bio
Sep 14, 2021
―
Informative Buy
779.61M
$2.87B
ATTO
Attovia Therapeutics, Inc.
Aug 07, 2026
Ten Percent Owner
Uninformative Buy
―
$16.45M
ALNY
Alnylam Pharma
Jun 01, 2017
Ten Percent Owner
Informative Buy
21.38M
$1.69B
RGLS
Regulus
Feb 05, 2014
―
Informative Buy
10.00M
$41.24M
SCYX
SCYNEXIS
May 09, 2014
Ten Percent Owner
Informative Buy
―
$6.32M
CBIO
Crescent Biopharma
Nov 06, 2013
Ten Percent Owner
Informative Buy
―
$16.09M
HGENQ
Humanigen
Feb 07, 2013
―
Informative Buy
700.00K
$6.37K
List of latest transactions for each holding click on a transaction to see Sanofi's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Sanofi insider profile FAQ

What is the percentage of profitable transactions made by Sanofi?
The percentage of profitable transactions made by Sanofi is 60%.
    What is the average return per transaction made by Sanofi?
    The average return per transaction made by Sanofi is 15.00%.
      What stocks does Sanofi hold?
      Sanofi holds: LTGO, REGN, MYOK, FULC, INZY, ICVX, ~TBIO, ATTO, ALNY, RGLS, SCYX, CBIO, HGENQ stocks.
        What was Sanofi’s latest transaction?
        Sanofi latest transaction was an Uninformative Buy of ―.
          What was Sanofi's most profitable transaction?
          Sanofi’s most profitable transaction was an Informative Buy of MYOK stock on October 5, 2016. The return on the trade was 145.60%.
            What is Sanofi's role in Latigo Biotherapeutics, Inc.?
            Sanofi's role in Latigo Biotherapeutics, Inc. is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.